Bruker supplies scientific instruments and analytical systems for life-science research, materials science, industrial analysis and clinical diagnostics. Its portfolio includes mass spectrometers, nuclear magnetic resonance systems, X-ray instruments and related software and consumables. Customers range from academic and government labs to pharmaceutical companies and industrial quality-control users who need high-end measurement and imaging tools.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q2 2025 | 797.4 | — | 7.6 | — |
| Q3 2025 | 860.5 | — | -62.4 | — |
| Q4 2025 | 977.2 | — | 14.9 | — |
| Q1 2026 | 823.4 | — | 3.5 | — |
| Q2 2026 | 838.5 | 5.2% | -62.9 | -927.6% |
All markets — KeepWinning global stock screener
Other companies on Nasdaq: Protagonist Therapeutics, Inc. (PTGX), Lineage, Inc. (LINE), TG Therapeutics, Inc. (TGTX), InterDigital, Inc. (IDCC), Axsome Therapeutics, Inc. (AXSM), Viavi Solutions Inc. (VIAV)